Literature DB >> 33577927

A contemporary update on hyalinizing clear cell carcinoma: compilation of all in-house cases at our institution and a literature review spanning 2015-2020.

Maria A Gubbiotti1, Kathleen Montone1, Paul Zhang1, Virginia Livolsi1, Zubair Baloch2.   

Abstract

Tumors of the head and neck with clear cell features prompt a broad differential diagnosis. A relatively uncommon, but increasingly recognized, entity is hyalinizing clear cell carcinoma (HCCC). This neoplasm, first described in 1994, consists of clear cells arranged in nests or trabecule with a hyalinized stroma. These are low-grade neoplasms that only infrequently metastasize and rarely recur. They also often harbor a unique EWSR-ATF1 gene rearrangement. As the prognosis is excellent compared with other clear cell neoplasms, the correct diagnosis is key. Here we present all of the cases of HCCC in the past decade from our institution alongside a comprehensive literature review spanning 2015-2020 to further characterize this unusual malignancy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EWSR-ATF1; Head and neck; Hyalinizing clear cell carcinoma; Oral cavity

Year:  2021        PMID: 33577927     DOI: 10.1016/j.humpath.2021.01.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Clinicopathological and molecular study of 10 salivary gland clear cell carcinomas, with emphasis on rare cases with high grade transformation and occurring in uncommon sites.

Authors:  Lanlan Xuan; Suxia Wang; Jianguo Wei; Jianwei Yuan; Honggang Liu
Journal:  Diagn Pathol       Date:  2022-01-30       Impact factor: 2.644

Review 2.  Primary lung hyalinizing clear cell carcinoma: a diagnostic challenge in biopsy.

Authors:  Yanling Zhang; Wen Han; Jun Zhou; Xiang Yong
Journal:  Diagn Pathol       Date:  2022-03-27       Impact factor: 2.644

3.  Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.

Authors:  Ding Wu; Zhenyu Xu; Zhan Shi; Ping Li; Huichen Lv; Jie Huang; Dian Fu
Journal:  Comput Math Methods Med       Date:  2022-08-30       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.